Market›Health Care›Health Care Equipment & Supplies›Health Care Equipment
INTELLIGENT BIO SOLU

INBS

$2.55Apr 26, 2021 – Apr 24, 2026
Health CareHealth Care Equipment & SuppliesHealth Care Equipment$5M
MVM
-$0.1M
TD Variance
-1.000

Every news event mapped to its market reaction — 93 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2023-11-09+153.9%newsCNNsymbol__ Stock Quote Price and Forecast - CNN
2025-12-30+122.5%newsStocktwitsWhy Is INBS Stock Rising Today? - Stocktwits
2023-11-08+109.8%earningsSeeking AlphaIntelligent Bio Solutions GAAP EPS of -$1.04 misses by $0.40, revenue of $0.8M misses by $0.15M
2024-02-09+107.8%earningsSeeking AlphaIntelligent Bio Solutions GAAP EPS of -$2.07 beats by $1.17, revenue of $0.76M misses by $0.25M
2025-12-31+93.0%expansionSeeking AlphaIntelligent Bio Solutions launches $10M private placement
2025-12-31+93.0%newsTrefisCan Intelligent Bio Solutions Stock Recover If Markets Fall? - Trefis
2025-12-31+93.0%legalStock TitanMedical test firm secures $10M from healthcare investors - Stock Titan
2025-12-31+93.0%newsStock TitanFingerprint drug tests scale up as maker cuts costs by over 40% - Stock Titan
2025-12-31+93.0%newsBenzingaWhy Is Intelligent Bio Stock Soaring Wednesday? - Intelligent Bio Solutions (NASDAQ:INBS) - Benzinga
2025-12-31+93.0%newsStocksToTradeIntelligent Bio Solutions’ Strategic Leap: What’s Next?​ - StocksToTrade
2025-12-31+93.0%newsInvesting.com CanadaINBS partners with Syrma Johari to boost production, improve margins By Investing.com - Investing.com Canada
2025-12-31+93.0%expansionparameter.ioIntelligent Bio Solutions Inc. (INBS) stock: soars as new strategic manufacturing partnership fuels margin growth and capacity expansion - parameter.io
2023-10-02-54.9%newsSeeking AlphaIntelligent Bio Solutions announces pricing of $4M underwritten public offering
2023-10-02-54.9%newsInvestorPlaceWhy Is Intelligent Bio Solutions (INBS) Stock Down 52% Today? - InvestorPlace
2026-01-08+50.7%newsTipRanksIntelligent Bio Solutions Regains Nasdaq Listing Compliance Status - TipRanks
2024-02-02+50.4%earningsSeeking AlphaIntelligent Bio Solutions expects Q2 revenue to more than double
2023-02-09-36.2%newsGlobeNewswireIntelligent Bio Solutions Inc. Announces Reverse Stock Split - GlobeNewswire
2024-01-25-27.4%newsSeeking AlphaIntelligent Bio Solutions announces 1-for-12 reverse stock split
2024-01-25-27.4%newsYahoo FinanceIntelligent Bio Solutions Inc. Announces Reverse Stock Split - Yahoo Finance
2025-02-06+25.3%earningsSeeking AlphaIntelligent Bio Solutions reports preliminary Q2 revenue $0.61M
2024-09-09+23.1%earningsSeeking AlphaIntelligent Bio Solutions stock rallies on reporting Q4 revenue of $0.73M, up 64% Y/Y
2025-12-12-22.9%newsQuiver QuantitativeIntelligent Bio Solutions Inc. Announces 1-for-10 Reverse Stock Split Effective December 15, 2025 - Quiver Quantitative
2025-12-12-22.9%newsStock TitanIntelligent Bio Solutions (Nasdaq: INBS) to implement 1-for-10 reverse stock split effective Dec. 15 - Stock Titan
2024-02-12-18.6%newsInvestorPlaceWhy Is Intelligent Bio Solutions (INBS) Stock Down 24% Today? - InvestorPlace
2026-04-02-16.9%legalGlobeNewswireIntelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market
2026-04-02-16.9%expansionStock TitanA fingerprint drug test moved closer to a U.S. launch after codeine study - Stock Titan
2024-09-19-15.4%earningsSeeking AlphaIntelligent Bio Solutions GAAP EPS of -$6.38, revenue of $3.11M
2025-02-19-15.1%newsSeeking AlphaIntelligent Bio Solutions shares fall on proposed offering of common stock
2024-05-08-15.1%earningsSeeking AlphaIntelligent Bio Solutions GAAP EPS of -$1.43 misses by $0.56, revenue of $0.82M misses by $0.37M
2026-01-02+14.6%newsBenzingaWhy Intelligent Bio Solutions Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Fri - Benzinga
2026-01-02+14.6%expansionTradingViewIntelligent Bio Solutions Signs Multiple Financing Agreements - TradingView
2026-01-02+14.6%newsBenzingaWhat's Going On With Intelligent Bio Stock Friday? - Benzinga
2026-01-02+14.6%newsGlobeNewswireIntelligent Bio Solutions Announces Closing of $10.0 - GlobeNewswire
2026-01-02+14.6%expansionFinvizINBS Stock Surges 132.4% on New Manufacturing Partnership - Finviz
2026-01-02+14.6%newsTechStock²INBS stock drops today as Intelligent Bio Solutions’ $10M private placement puts dilution in focus - TechStock²
2026-01-02+14.6%newsBenzingaOutlook Therapeutics, Intelligent Bio Solutions And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
2026-01-02+14.6%newsInvesting.com UKIntelligent Bio Solutions closes $10 million private placement By Investing.com - Investing.com UK
2026-01-02+14.6%newsBenzingaStock Market Today: S&P 500, Dow Futures Gain On The First Trading Day Of 2026— Baidu, Rubico, Intelligen - Benzinga
2025-02-20-14.2%newsSeeking AlphaIntelligent Bio Solutions announces pricing of $2.6 million public offering; shares fall
2023-11-06-13.8%newsChartMillINBS Stock Price, Quote & Chart | INTELLIGENT BIO SOLUTIONS IN (NASDAQ:INBS) - ChartMill
2026-01-14-13.3%analystInvestor's Business DailyStocks To Watch: Intelligent Bio Solutions Sees Relative Strength Rating Rise To 85 - Investor's Business Daily
2025-06-02+12.3%newsIntellectia AIINBS Forecast — Price Prediction for 2026. Should I Buy INBS? - Intellectia AI
2026-02-05-11.1%earningsGlobeNewswireIntelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48% Year-Over-Year, Surpassing $2 Million in Total Revenue for First Half of Fiscal Year
2026-04-20+10.6%newsGlobeNewswireIntelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results
2026-04-20+10.6%newsStock TitanFingerprint drug test aims for under-3-minute roadside results - Stock Titan
2026-04-20+10.6%newsTipRanksIntelligent Bio Solutions Updates Investor Presentation and Share Count - TipRanks
2026-04-20+10.6%newsStock TitanIntelligent Bio Solutions (NASDAQ: INBS) posts new investor deck and share update - Stock Titan
2025-11-12-9.5%earningsSeeking AlphaIntelligent Bio Solutions GAAP EPS of -$0.35, revenue of $1.11M
2025-09-30-9.5%newsTradingKeyINBS|Intelligent Bio Solutions Inc|Price:2.520|Chg%:-0.11 - TradingKey
2024-06-27+8.7%legalSeeking AlphaIntelligent Bio Solutions expands presence in the UK retail sector
2026-03-16-8.5%newsDailyhuntWhy Is INBS Stock Rising Today? - Dailyhunt
2026-02-24-8.4%newsGlobeNewswireIntelligent Bio Solutions Partners with Bouygues UK, Part of Multi-Billion Dollar Global Construction Giant Bouygues Construction, for UK Drug Testing Rollout
2026-02-24-8.4%newsStock TitanConstruction giant brings drug tests in-house with fingerprint scans at UK sites - Stock Titan
2022-10-28-8.2%newsTradingViewTechnical Analysis of Intelligent Bio Solutions Inc. (NASDAQ:INBS) - TradingView
2026-04-17+7.5%earningsGlobeNewswireIntelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified
2026-04-17+7.5%legalStock TitanNo major security flaws found as Intelligent Bio readies FDA filing - Stock Titan
2025-02-07+7.4%expansionSeeking AlphaIntelligent Bio Solutions expands with UK partnership
2025-06-18-7.2%newssimplywall.stThe Future of Drug Testing? Fingerprint Tech From Intelligent Bio Solutions (NASDAQ:INBS) Shows Serious Promise - simplywall.st
2026-01-12-6.9%newsStocktwitsINBS Stock Gains Triple-Digit Rally So Far In January: What’s Driving The Surge And What Traders Are Saying - Stocktwits
2026-01-12-6.9%newsStocktwitsThis Diagnostics Stock Is Surging 23% Pre-Market Today – Here’s Why - Stocktwits
2024-10-29-6.8%earningsSeeking AlphaIntelligent Bio Solutions sees Q1 revenue of $0.87M
2023-04-06+6.1%newsCoinCodexIntelligent Bio Solutions Inc. (INBS) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
2024-11-07+6.0%earningsSeeking AlphaIntelligent Bio Solutions GAAP EPS of -$0.70, revenue of $0.87M
2022-10-29-5.9%analystZacks Investment ResearchWhat is the current Price Target and Forecast for INTLGNT BIO SOL (INBS) - Zacks Investment Research
2026-02-25-5.8%analystGlobeNewswireIntelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry
2026-02-25-5.8%earningsStock TitanDrug test readers scaled 4x as Intelligent Bio preps for U.S. entry - Stock Titan
2024-09-03-5.5%newsSeeking AlphaIntelligent Bio Solutions doubles its customer employee base
2026-03-23-4.8%newsTipRanksIntelligent Bio Solutions Grants Equity Awards, Updates ATM Capacity - TipRanks
2025-05-13+4.5%earningsSeeking AlphaIntelligent Bio Solutions GAAP EPS of -$0.44, revenue of $0.73M
2025-08-19-3.9%newsSeeking AlphaIntelligent Bio Solutions rise on record cartridge sales
2024-04-18+3.3%earningsSeeking AlphaIntelligent Bio Solutions reports Preliminary Unaudited Fiscal Q3 results
2024-04-18+3.3%earningsSeeking AlphaIntelligent Bio Solutions expects approximate unaudited Q3 revenue of $0.82M
2025-08-07-3.3%earningsSeeking AlphaIntelligent Bio Solutions expects 16% year over year growth in fourth quarter revenue
2024-06-20-3.0%newsSeeking AlphaIntelligent Bio gains as UK customer base increases with two new major accounts
2026-02-12-2.9%earningsGlobeNewswireIntelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-Year
2026-02-12-2.9%earningsSeeking AlphaIntelligent Bio Solutions GAAP EPS of -$2.82, revenue of $0.89M
2025-12-18+2.6%newsStock TitanWearable patch collaboration could change how health is monitored - Stock Titan
2025-09-02-2.3%newsQuiver QuantitativeINBS | Intelligent Bio Solutions Inc. Institutional Ownership - Quiver Quantitative
2022-10-27-2.3%newsTradingViewINBS Stock Price and Chart — NASDAQ:INBS - TradingView
2026-01-28+1.8%earningsGlobeNewswireIntelligent Bio Solutions Initiates Additional Clinical Studies for FDA 510(k) Submission Supporting Planned Entry into Multi-Billion Dollar U.S. Market
2026-01-28+1.8%legalStock TitanFinger-scan drug test starts trials for FDA bid in multi-billion U.S. market - Stock Titan
2025-08-15+1.6%earningsSeeking AlphaIntelligent Bio Solutions GAAP EPS of -$2.00, revenue of $3.05M
2025-02-13+1.4%earningsSeeking AlphaIntelligent Bio Solutions GAAP EPS of -$0.50, revenue of $0.61M
2023-08-24+1.2%newsSeeking AlphaIntelligent Bio Solutions reports FY 2023 results
2024-07-04-1.1%analystChartMillINBS Forecast, Price Target & Analyst Ratings | INTELLIGENT BIO SOLUTIONS IN (NASDAQ:INBS) - ChartMill
2024-06-19-1.1%earningsYahoo FinanceWhen Will Intelligent Bio Solutions Inc. (NASDAQ:INBS) Become Profitable? - Yahoo Finance
2026-03-20+0.7%newsStock TitanDirector at Intelligent Bio Solutions (INBS) granted 5,000 shares - Stock Titan
2025-10-23+0.6%legalStock TitanIntelligent Bio Solutions (Nasdaq: INBS) secures UK deployment with 30,000-staff group - Stock Titan
2025-11-25-0.6%newsStocksToTradeIntelligent Bio Solutions Inc. (INBS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
2026-03-26-0.4%newsGlobeNewswireIntelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant
2026-03-26-0.4%newsStock TitanA fingerprint sweat drug test just won its 8th European patent - Stock Titan
2025-07-30-0.1%legalSeeking AlphaIntelligent Bio Solutions secures drug testing tender with a London transport operator
2024-03-11+0.1%newsSeeking AlphaIntelligent Bio Solutions announces $10M private placement pricedat-the-market under Nasdaq rules
tickerdossier.comtickerdossier.substack.com